Drug Class Insights in the CIPN Treatment Market
Despite promising growth opportunities, the market faces certain challenges such as limited approved therapies specifically designed for CIPN and the complexity of diagnosing neuropathy symptoms accurately.
The chemotherapy-induced peripheral neuropathy (CIPN) treatment market is gaining significant attention within the global healthcare and oncology sectors. CIPN is a common and often...
0 Yorum
0 Paylar
English